Dynamic contrast-enhanced MRI studies in human tumours

British Journal of Radiology

Volumn 72, Issue MAY, 1999, Pages 427-431

  Padhani, A R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; SHORT SURVEY; TUMOR DIAGNOSIS;

EID: 0032972937     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.72.857.10505003     Document Type: Short Survey

References (37)

1. Passe TJ, Bluemke DA, Siegelman SS. Tumour angiogenesis: tutorial on implications for imaging. Radiology 1997;203:593-600.
2. Folkman J. What is the evidence that tumours are angiogenesis dependent? J Nat Can Inst 1990; 82:4-6.
3. Weidner N. Intratumoral microvessel density as a prognostic factor in cancer (comment). Am J Pathol 1995;147:1029-39.
4. Rosen BR, Belliveau JW, Aronen HJ, Kennedy D, Buchbinder BR, Fischman A, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med 1991;22:293-9.
5. 2*-weighted MR imaging at 1.5 T. Radiology 1990; 176:211-20.
6. Fisel CR, Ackerman JL, Buxton RB, Garrido L, Belliveau JW, Rosen BR, et al. MR contrast due to microscopic heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991;17:336-47.
7. Rempp KA, Brix G, Wenz F, Becker CR, Guckel F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193:637-41.
8. Wenz F, Rempp K, Hess T, Debus J, Brix G, Engenhart R, et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. AJR 1996; 166:187-93.
9. Aronen HJ, Boxerman JL, Goldberg IE, Weisskoff RM, Belliveau JW, Provenzale JM, et al. Susceptibility contrast CBV mapping: optimisation of contrast dose and imaging sequences. In: Proceedings of the 11th Annual Meeting of the Society of Magnetic Resonance in Medicine, 1992, August 8-14, Berlin. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1992.
10. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Characterization of hepatic lesions by perfusion-weighted MR imaging with an echoplanar sequence. AJR 1998;170:1029-34.
11. 2* susceptibility-contrast, first-pass perfusion MR imaging. Radiology 1997;202:87-95.
12. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, et al. Cerebral blood volume maps of gliomas: comparison with tumour grade and histologic findings. Radiology 1994; 191:41-51.
13. Aronen HJ, Glass J, Pardo FS, Belliveau JW, Gruber ML, Buchbinder BR, et al. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. Acta Radiol 1995;36:520-8.
14. De la Paz RL, Ott IL, Paola T. Recurrent brain tumour versus radiation necrosis: comparison of MR relative cerebral blood volume maps and FDG-PET. Radiology 1995;197(P):169.
15. 2 contrast-enhanced imaging. Magn Reson Med 1991;22:259-64.
16. Lev MH, Kulke SF, Sorensen AG, Boxerman JL, Brady TJ, Rosen BR, et al. Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection. J Magn Reson Imaging 1997;7:523-7.
17. Tofts PS. Modelling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
18. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991;17:357-67.
19. den Boer JA, Hoenderop RK, Smink J, Dornseiffen G, Koch PW, Mulder JH, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 1997;7:702-15.
20. Tofts PS, Berkowitz B, Schnall MD. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995;33:564-8.
21. Heywang-Kobrunner SH. Appearance of various tissues and lesions. In: Heywang-Kobrunner SH, Beck R (editors). Contrast-enhanced MRI of the breast (2nd edn). Berlin: Springer-Verlag, 1996;57-156.
22. Verstraete KL, De Deene Y, Roels H, Dierick A, Uyttendaele D, Kunnen M. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology 1994;192:835-43.
23. Brinck U, Fischer U, Korabiowska M, Jutrowski M, Schauer A, Grabbe E. The variability of fibro-adenoma in contrast-enhanced dynamic MR mammography. AJR 1997;168:1331-4.
24. Barentsz JO, Jager GJ, van Vierzen PB, Witjes JA, Strijk SP, Peters H, et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 1996;201:185-93.
25. Jager GJ, Ruijter ET, van de Kaa CA, de la Rosette JJ, Oosterhof GO, Thornbury JR, et al. Dynamic turboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. Radiology 1997; 203:645-52.
26. van der Woude HJ, Bloem JL, Verstraete KL, Taminiau AH, Nooy MA, Hogendoorn PC. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR 1995;165:593-8.
27. Knopp MV, Brix G, Junkermann HJ, Sinn HP. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 1994;2:633-58.
28. Padhani AR, Gapinski C, Revell PB, Parker GJM, Suckling J, MacVicar D, et al. Effect of hormonal treatment on prostate morphology, tumour detection and tumour vascular permeability. In: Proceedings of the International Society for Magnetic Resonance in Medicine, 6th Scientific Meeting, April 18-24 1998, Sydney. Berkeley, CA: International Society for Magnetic Resonance in Medicine, 1998.
29. Mayr NA, Yuh WT, Magnotta VA, Ehrhardt JC, Wheeler JA, Sorosky JI, et al. Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay. Int J Radiat Oncol Biol Phys 1996;36:623-33.
30. Dao TH, Rahmouni A, Campana F, Laurent M, Asselain B, Fourquet A. Tumour recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 1993;187:751-5.
31. Gilles R, Guinebretiere JM, Shapeero LG, Lesnik A, Contesso G, Sarrazin D, et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. Radiology 1993;188:473-8.
32. Kinkel K, Tardivon AA, Soyer P, Spatz A, Lasser P, Rougier P, et al. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: A prospective study of 41 patients. Radiology 1996;200:453-8.
33. Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Erning LJ, Hendriks JH, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994;193:777-81.
34. Heywang-Kobrunner SH, Haustein J, Pohl C, Beck R, Lommatzsch B, Untch M, et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 1994;191:639-46.
35. Parker GJM, Suckling J, Tanner SF, Padhani AR, Revell PB, Husband JE, et al. Probing tumour microvessel density by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997;7:564-74.
36. Parker GJ, Suckling J, Tanner SF, Padhani AR, Husband JE, Leach MO. MRIW: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. RadioGraphics 1998;18:497-506.
37. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ. Pharmacokinetic mapping of the breast: a new method for dynamic MR mammography. Magn Reson Med 1995;33:506-14.